
Speakers:
- Akihiro Ogawa (University of Melbourne’s Asia Institute)
Moderator:
- Kyle Cleveland, ICAS Co-Director
This book illuminates how Japanese civil society navigates a crisis time while maintaining its democratic participation in policy creation following the March 11 disaster. Professor Ogawa documented in his detailed ethnography the actions of survivors who must live a new reality in post-Fukushima Japan. The primary agents for change are what he calls “antinuclear citizens”—conscientious citizens who envision a sustainable life in a nuclear-free society. Those people imagined new, workable, and sustainable ideas, subjectivities, technologies, and knowledge. Throughout the book, Dr. Ogawa addresses a key question: How have grassroots civic actions exploring sustainability influenced national and global agendas? He makes a powerful statement against the state-dominant discourse of nuclear politics by presenting local antinuclear voices and experiences and highlighting the limits in social and political life.
Antinuclear Citizens
Sustainability Policy and Grassroots Activism in Post-Fukushima Japan
STANFORD UNIVERSITY PRESS New Tab
Friday, July 21, 2023 18:00
Registration is not required for meeting access:
https://temple.zoom.us/j/92398311326
Temple University, Japan Campus Room 306 (Access)
Registration is not required (e-mail to icas@tuj.temple.edu).
This event is organized by the Institute of Contemporary Asian Studies (ICAS).
Note: All ICAS events are held in English, open to the public, and admission is free unless otherwise noted.
Akihiro Ogawa is the Japanese Studies Chair at the University of Melbourne’s Asia Institute. Trained as an anthropologist, his major research interest is contemporary Japan and Asia, focusing on civil society and politics. His publications include the award-winning book, The Failure of Civil Society? (2009), Lifelong Learning in Neoliberal Japan (2015), and edited volumes such as Routledge Handbook of Civil Society in Asia (2017) and Transnational Civil Society in Asia (2021, with Avenell), along with many journal articles and book chapters.